Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
J Am Acad Dermatol ; 79(5): 878-883, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29864465

RESUMEN

BACKGROUND: Folliculitis decalvans (FD) is a rare neutrophilic cicatricial alopecia that poses a therapeutic challenge. OBJECTIVES: To describe the therapeutic response in a large number of cases of FD with long-term follow-up and analyze potential prognostic factors associated with severity of form and with a better therapeutic response. METHODS: This multicenter prospective study included patients with FD who had a minimum of 5 years of follow-up. Severity was assessed by the maximum diameter of the cicatricial area. Therapeutic response was evaluated according to stabilization of the size of the cicatricial areas and the improvement in clinical symptoms. RESULTS: A total of 60 patients (37 men [61.7%] and 23 women [38.3%]) with a mean age of 40 years were included. Earlier age of onset (P = .01) was statistically associated with severity of form. Treatment with rifampicin and clindamycin, tetracyclines, and intralesional steroids was the most effective. No statistically significant prognostic factors predicting a better therapeutic response were found. LIMITATIONS: Because FD is a rare disease, the main limitation was the sample size. CONCLUSIONS: An earlier age of onset was associated with the severe form of the disease. The proposed specific therapeutic protocol can be a very useful tool in clinical dermatologic practice.


Asunto(s)
Alopecia/patología , Foliculitis/tratamiento farmacológico , Foliculitis/patología , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Dermatosis del Cuero Cabelludo/patología , Corticoesteroides/uso terapéutico , Alopecia/tratamiento farmacológico , Alopecia/etiología , Antibacterianos/uso terapéutico , Cicatriz/tratamiento farmacológico , Cicatriz/patología , Estudios de Cohortes , Terapia Combinada , Femenino , Foliculitis/complicaciones , Estudios de Seguimiento , Humanos , Isotretinoína/uso terapéutico , Masculino , Minoxidil/uso terapéutico , Análisis Multivariante , Fotoquimioterapia/métodos , Estudios Retrospectivos , Medición de Riesgo , Dermatosis del Cuero Cabelludo/complicaciones , España , Factores de Tiempo , Resultado del Tratamiento
3.
Int J Dermatol ; 56(12): 1451-1454, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28960299

RESUMEN

BACKGROUND: Erosive adenoma of the nipple (EAN) is a benign condition that involves major ducts of the nipple. Its clinical presentation may resemble other disorders. Complete removal of the nipple is often suggested because of frequent relapse. However, adverse cosmetic and functional results have prompted clinicians to look for other more conservative options. AIMS: To present a case of EAN successfully treated using Mohs micrographic surgery (MMS) and summarize differential diagnosis and treatment. MATERIALS AND METHODS: A 40-year-old woman with EAN was diagnosed by immunohistochemical markers after clinical suspicion. We have reviewed other cases treated with MMS in the literature. RESULTS: In this patient, lesion size was 0.8 cm and the margin specimen was 1 × 0.9 × 0.2 cm, with EAN as histopathologic diagnosis. No atypia or malignancy was reported. Final esthetic outcome was reached with only one session, under local anesthesia and on an outpatient basis. DISCUSSION: Dermatologic lesions appearing on the nipple's surface should be closely followed. Paget's disease, carcinoma or proliferative lesions like EAN have to be considered, and such conditions require different surgical approaches. Traditional complete removal of the nipple is performed in many cases, but it may result in over-treatment and unfavorable cosmetic outcome. MMS is frequently used in dermatologic surgery to treat malignant lesions with a high cure rate, avoiding excess tissue excision and leading to better patient satisfaction. CONCLUSION: EAN can be successfully treated by minimal resection, especially if early diagnosis is done. MMS offers a better aesthetic outcome than traditional total excision.


Asunto(s)
Adenoma/cirugía , Neoplasias de la Mama/cirugía , Cirugía de Mohs , Pezones/cirugía , Neoplasias Cutáneas/cirugía , Adulto , Femenino , Humanos
4.
Dermatology ; 220(2): 154-8, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20110631

RESUMEN

Acrodermatitis continua of Hallopeau (ACH) is a rare acropustular eruption, characterized by sterile pustules, paronychia and atrophic skin changes, onychodystrophy and osteolysis of the distal phalanges of the fingers and toes. It is considered to be a variant of pustular psoriasis with a chronic relapsing course and frequent refractoriness to many therapeutic modalities, which can be amenable to successful treatment by tumor necrosis factor alpha antagonists. We report 1 patient with pustular psoriasis and ACH whom we have treated successfully with etanercept (for 30 months) and then adalimumab (for 13 months and ongoing). Blanching was initially achieved with etanercept 50 mg twice a week, but suppression of periungual inflammation then required combination therapy with etanercept 50 mg twice a week and methotrexate 10 mg weekly; lower doses of both drugs did not allow complete control of the disease. Eventually, adalimumab 40 mg every 2 weeks has provided the most cost-effective response in this patient, allowing maintenance of response with partial nail regrowth under monotherapy.


Asunto(s)
Acrodermatitis/tratamiento farmacológico , Anticuerpos Monoclonales/uso terapéutico , Inmunoglobulina G/uso terapéutico , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Inhibidores del Factor de Necrosis Tumoral , Acitretina/uso terapéutico , Adalimumab , Anciano , Anticuerpos Monoclonales/economía , Anticuerpos Monoclonales Humanizados , Betametasona/uso terapéutico , Clobetasol/uso terapéutico , Ciclosporina/uso terapéutico , Quimioterapia Combinada , Etanercept , Femenino , Humanos , Metotrexato/uso terapéutico , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapéutico , Uñas/efectos de los fármacos , Uñas/patología , Paroniquia/tratamiento farmacológico , Psoriasis/tratamiento farmacológico
5.
Dermatology ; 220(1): 71-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19940453

RESUMEN

Published experiences of TNF-alpha inhibition during pregnancy consist of a limited number of case reports, series and ongoing registry data in patients with arthritis and inflammatory bowel disease. A 28-year-old woman - with psoriasis vulgaris since she was 8 years of age and generalized pustular psoriasis during her first pregnancy (partially controlled with ciclosporin, oral prednisone and topical corticosteroids, when lupus anticoagulant was detected at another hospital) - presented 4 months after delivery with severe psoriasis (PASI = 15.4) that did not respond to ciclosporin (3 mg/kg/day). Ten days after the first infusion of infliximab (5 mg/kg), when the patient became aware that she was pregnant again, there was PASI75 response, and the patient wished to continue this treatment after being fully informed. Complete blanching was achieved by week 6 of treatment, and was maintained thereafter until the moment of writing (19 months after the start of treatment). She gave birth by caesarean delivery to a healthy female baby, who was breastfed for 1 month and has developed normally. The current report extends the available evidence on successful infliximab treatment in pregnant women, with the first case of a patient with psoriasis who presented impetigo herpetiformis during her previous pregnancy. No detectable adverse effects were detected in the neonate, despite potential exposure to infliximab throughout gestation and breastfeeding. Even though absolute safety is difficult to prove, available data suggest that women who become pregnant while taking infliximab or other anti-TNFalpha agents can be reassured regarding the continuation of pregnancy.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Psoriasis/tratamiento farmacológico , Inhibidores del Factor de Necrosis Tumoral , Corticoesteroides/uso terapéutico , Ciclosporina/uso terapéutico , Femenino , Humanos , Recién Nacido , Infliximab , Embarazo , Resultado del Tratamiento
6.
Dermatol Reports ; 2(1): e5, 2010 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-25386241

RESUMEN

We report the case of a 75-year old woman with collagenous colitis who presented with erythematous and edematous plaques on the periorbital and eyelid regions, accompanied by oral ulcers. Histopathology showed a dermal neutrophilic infiltrate plus mild septal and lobular panniculitis with lymphocytes, neutrophils and eosinophils. Five years earlier she had presented a flare of papules and vesicles on the trunk, together with oral ulcers; a skin biopsy revealed a neutrophilic dermal infiltrate and Sweet's syndrome was diagnosed. Both the neutrophilic panniculitis and the Sweet's syndrome were accompanied by fever, malaise and diarrhea. Cutaneous and intestinal symptoms disappeared with corticoid therapy. The two types of neutrophilic dermatoses that appeared in periods of colitis activity suggest that intestinal and cutaneous manifestations may be related.

8.
Hum Pathol ; 40(5): 624-30, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19157499

RESUMEN

To study the different patterns of Treponema pallidum distribution in primary and secondary syphilis, 34 biopsy specimens of 8 patients with primary and 26 with secondary syphilis were assessed. Histopathological features, silver stain, and immunohistochemical T pallidum polyclonal antibody expression were investigated. The number and distribution of spirochetes were evaluated, and ultrastructural studies were performed. Spirochetes were identified with Warthin-Starry stain in 17 specimens (4/8 primary and 13/26 secondary syphilis), whereas immunohistochemical analysis disclosed spirochetes in 29 (8/8 primary and 21/26 secondary syphilis). In secondary syphilis, an epitheliotropic pattern characterized by abundant spirochetes in the lower mucosa/epidermis in an intercellular distribution was observed. In contrast, primary syphilis exhibited a mixed epitheliotropic and vasculotropic pattern further manifested by treponemes surrounding the vascular walls. These differences were statistically significant. Ultrastructural examination confirmed these results. Immunohistochemistry shows greater sensitivity when compared with Warthin-Starry staining. The immunohistochemical pattern of T pallidum distribution may permit the diagnostic differentiation of primary from secondary syphilis.


Asunto(s)
Sífilis/microbiología , Infecciones por Treponema/microbiología , Adulto , Femenino , Humanos , Inmunohistoquímica , Masculino , Membrana Mucosa/microbiología , Membrana Mucosa/ultraestructura , Spirochaetales/ultraestructura , Sífilis/patología , Sífilis Cutánea/microbiología , Sífilis Cutánea/patología , Treponema pallidum , Infecciones por Treponema/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...